{
  "prompt": {
    "prompt": "Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\n\nFor each recommendation, specify:\n1. The type of recommendation:\n   - Additional information needed (history/examination/investigations)\n   - Improved patient advice (options/statistics/patient information)\n   - Different management plan\n2. The specific recommendation\n3. The reason for the recommendation (referencing the guideline)\n\nCategorize each recommendation by importance:\n- Very Important: Critical for patient safety or guideline compliance\n- Somewhat Important: Significant for optimal care but not critical\n- Less Important: Would improve care but not essential\n- Unimportant: Minor suggestions that could be considered\n\nFormat the response as follows:\n\n### Very Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Somewhat Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Less Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Unimportant Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\nClinical Note:\nDictation: Clinical Interaction – Twin Pregnancy with Obstetric Cholestasis\n Patient Details:\nName: [Fictional Name] Sarah Ahmed\n\n\nAge: 32\n\n\nBMI: 24.7 (weight 68 kg, height 1.66 m)\n\n\nGravida: 2, Para: 1 (previous spontaneous vaginal delivery at term)\n\n\nCurrent Gestation: 32+2 weeks (DCDA twins confirmed on early scan)\n\n\nBooking bloods and anomaly scans: Unremarkable\n\n\nHistory of Presenting Complaint:\n Ms. Ahmed presents with a 10-day history of worsening pruritus, predominantly affecting her palms and soles, with associated sleep disturbance. She denies any new skin rashes or recent medication changes. No history of abdominal pain, dark urine, or pale stools. Fetal movements are reported as normal for both twins. No vaginal bleeding or uterine tightenings.\nRelevant Obstetric History:\nPrevious pregnancy uncomplicated; term vaginal delivery.\n\n\nNo history of intrahepatic cholestasis in prior pregnancy.\n\n\nNo history of preterm labour or hypertensive disorders.\n\n\nRelevant Medical History:\nMild childhood asthma (not on regular treatment).\n\n\nNo known liver or gallbladder disease.\n\n\nMedications & Allergies:\nCurrently taking ferrous fumarate and pregnancy multivitamin.\n\n\nNo known drug allergies.\n\n\nSocial History:\nLives with husband and toddler son.\n\n\nNon-smoker; does not consume alcohol.\n\n\nWorks part-time as a dental nurse; currently on maternity leave.\n\n\nExamination Findings:\nGeneral: Alert and well, no jaundice noted.\n\n\nAbdomen: Uterus consistent with gestational age; fundal height 33 cm.\n\n\nTwins in cephalic/cephalic lie; both heartbeats auscultated and regular.\n\n\nNo uterine tenderness or signs of labour.\n\n\nNo peripheral oedema; BP 118/74 mmHg.\n\n\nNotable Omissions (for testing purposes):\nNo documented baseline bile acid levels from booking bloods.\n\n\nNo record of fetal growth scan within the last 2 weeks.\n\n\nNo documentation of CTG to assess current fetal wellbeing.\n\n\nImpression:\n Twin pregnancy (DCDA) complicated by suspected obstetric cholestasis. Pruritus in the absence of rash raises concern for intrahepatic cholestasis of pregnancy (ICP), particularly given gestation and multifetal pregnancy.\nManagement Plan:\nInvestigations:\n\n\nSerum bile acids and liver function tests (LFTs) urgently.\n\n\nFasting bile acids if initial results are borderline.\n\n\nFull blood count and clotting screen (due to potential risk of coagulopathy).\n\n\nCTG to assess fetal wellbeing.\n\n\nGrowth scan and umbilical artery Dopplers if not done in past 2 weeks.\n\n\nMedical Management:\n\n\nStart ursodeoxycholic acid 500 mg BID while awaiting results.\n\n\nConsider chlorphenamine for symptomatic relief of itching.\n\n\nOngoing Care and Delivery Planning:\n\n\nWeekly bile acids and LFTs.\n\n\nIncrease surveillance: twice-weekly CTGs and weekly growth scans.\n\n\nAim for delivery at 36–37 weeks if bile acids <100 µmol/L.\n\n\nConsider earlier delivery if bile acids ≥100 µmol/L or evidence of fetal compromise.\n\n\nCounseling Provided:\n\n\nDiscussed nature of obstetric cholestasis and increased risk of stillbirth in twin pregnancies.\n\n\nReassured about ongoing monitoring and early delivery plan.\n\n\nAdvised to monitor fetal movements closely and report any reduction.\n\n\nProvided written information and contact details for triage if symptoms worsen.\n\n\nDictated by: Dr. [Fictional Name] Patel\n Date: [Fictional Date]\n--Note: This is a fictional dictation for testing purposes only. No real patient data or medical advice is contained herein.\n\n\n\nGuideline:\n[ID] cg20013-preterm-birth-risk-pathway-pdf\nTitle: CG20013 Preterm birth risk pathway\nContent: No content available",
    "system_prompt": "You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.",
    "guideline_id": "cg20013-preterm-birth-risk-pathway-pdf",
    "guideline_title": "CG20013 Preterm birth risk pathway"
  },
  "response": "Since the guideline content (CG20013 Preterm birth risk pathway) is not available for review, I cannot make specific recommendations tied to that guideline. However, based on standard obstetric practice for twin pregnancies with suspected obstetric cholestasis, I can provide general recommendations for improvement of this clinical note:\n\n### Very Important Recommendations\n1. [Additional information needed] - Document baseline bile acid levels from booking bloods if available, or explicitly state they were not done\nReason: Baseline bile acids are crucial for comparison in suspected obstetric cholestasis cases (RCOG Green-top Guideline No. 43)\n\n2. [Different management plan] - Consider admission for monitoring given twin pregnancy with suspected cholestasis\nReason: Twin pregnancies with cholestasis have higher risk of adverse outcomes and may benefit from closer inpatient monitoring (RCOG)\n\n### Somewhat Important Recommendations\n1. [Additional information needed] - Document detailed counseling about specific risks of preterm delivery in twin pregnancy with cholestasis\nReason: Patients should understand the balance between fetal risks from cholestasis versus prematurity (SMFM guidelines on twin pregnancy)\n\n2. [Improved patient advice] - Provide specific written information about signs of preterm labor to watch for\nReason: Twin pregnancies have higher risk of preterm labor, especially with cholestasis (ACOG practice bulletin on multifetal gestations)\n\n### Less Important Recommendations\n1. [Additional information needed] - Consider adding total weight gain in pregnancy to documentation\nReason: Weight gain patterns may be relevant in twin pregnancies (NIH guidelines on twin pregnancy management)\n\n2. [Improved patient advice] - Suggest specific non-pharmacological itch relief measures (cool baths, loose clothing)\nReason: Can improve quality of life while awaiting medication effects (RCOG patient information leaflets)\n\nWithout access to the specific CG20013 guideline content, I cannot make recommendations that directly reference it. The recommendations above are based on general obstetric guidelines for management of twin pregnancies with suspected cholestasis. To provide more targeted feedback, the full text of the CG20013 guideline would need to be available for review.",
  "endpoint": "analyzeNoteAgainstGuideline",
  "timestamp": "2025-06-22T15-55-00",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"prompt\": \"Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\\n\\nFor each recommendation, specify:\\n1. The type of recommendation:\\n   - Additional information needed (history/examination/investigations)\\n   - Improved patient advice (options/statistics/patient information)\\n   - Different management plan\\n2. The specific recommendation\\n3. The reason for the recommendation (referencing the guideline)\\n\\nCategorize each recommendation by importance:\\n- Very Important: Critical for patient safety or guideline compliance\\n- Somewhat Important: Significant for optimal care but not critical\\n- Less Important: Would improve care but not essential\\n- Unimportant: Minor suggestions that could be considered\\n\\nFormat the response as follows:\\n\\n### Very Important Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\n### Somewhat Important Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\n### Less Important Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\n### Unimportant Recommendations\\n[Type] - [Specific recommendation]\\nReason: [Reference to guideline ID and relevant section]\\n\\nClinical Note:\\nDictation: Clinical Interaction – Twin Pregnancy with Obstetric Cholestasis\\n Patient Details:\\nName: [Fictional Name] Sarah Ahmed\\n\\n\\nAge: 32\\n\\n\\nBMI: 24.7 (weight 68 kg, height 1.66 m)\\n\\n\\nGravida: 2, Para: 1 (previous spontaneous vaginal delivery at term)\\n\\n\\nCurrent Gestation: 32+2 weeks (DCDA twins confirmed on early scan)\\n\\n\\nBooking bloods and anomaly scans: Unremarkable\\n\\n\\nHistory of Presenting Complaint:\\n Ms. Ahmed presents with a 10-day history of worsening pruritus, predominantly affecting her palms and soles, with associated sleep disturbance. She denies any new skin rashes or recent medication changes. No history of abdominal pain, dark urine, or pale stools. Fetal movements are reported as normal for both twins. No vaginal bleeding or uterine tightenings.\\nRelevant Obstetric History:\\nPrevious pregnancy uncomplicated; term vaginal delivery.\\n\\n\\nNo history of intrahepatic cholestasis in prior pregnancy.\\n\\n\\nNo history of preterm labour or hypertensive disorders.\\n\\n\\nRelevant Medical History:\\nMild childhood asthma (not on regular treatment).\\n\\n\\nNo known liver or gallbladder disease.\\n\\n\\nMedications & Allergies:\\nCurrently taking ferrous fumarate and pregnancy multivitamin.\\n\\n\\nNo known drug allergies.\\n\\n\\nSocial History:\\nLives with husband and toddler son.\\n\\n\\nNon-smoker; does not consume alcohol.\\n\\n\\nWorks part-time as a dental nurse; currently on maternity leave.\\n\\n\\nExamination Findings:\\nGeneral: Alert and well, no jaundice noted.\\n\\n\\nAbdomen: Uterus consistent with gestational age; fundal height 33 cm.\\n\\n\\nTwins in cephalic/cephalic lie; both heartbeats auscultated and regular.\\n\\n\\nNo uterine tenderness or signs of labour.\\n\\n\\nNo peripheral oedema; BP 118/74 mmHg.\\n\\n\\nNotable Omissions (for testing purposes):\\nNo documented baseline bile acid levels from booking bloods.\\n\\n\\nNo record of fetal growth scan within the last 2 weeks.\\n\\n\\nNo documentation of CTG to assess current fetal wellbeing.\\n\\n\\nImpression:\\n Twin pregnancy (DCDA) complicated by suspected obstetric cholestasis. Pruritus in the absence of rash raises concern for intrahepatic cholestasis of pregnancy (ICP), particularly given gestation and multifetal pregnancy.\\nManagement Plan:\\nInvestigations:\\n\\n\\nSerum bile acids and liver function tests (LFTs) urgently.\\n\\n\\nFasting bile acids if initial results are borderline.\\n\\n\\nFull blood count and clotting screen (due to potential risk of coagulopathy).\\n\\n\\nCTG to assess fetal wellbeing.\\n\\n\\nGrowth scan and umbilical artery Dopplers if not done in past 2 weeks.\\n\\n\\nMedical Management:\\n\\n\\nStart ursodeoxycholic acid 500 mg BID while awaiting results.\\n\\n\\nConsider chlorphenamine for symptomatic relief of itching.\\n\\n\\nOngoing Care and Delivery Planning:\\n\\n\\nWeekly bile acids and LFTs.\\n\\n\\nIncrease surveillance: twice-weekly CTGs and weekly growth scans.\\n\\n\\nAim for delivery at 36–37 weeks if bile acids <100 µmol/L.\\n\\n\\nConsider earlier delivery if bile acids ≥100 µmol/L or evidence of fetal compromise.\\n\\n\\nCounseling Provided:\\n\\n\\nDiscussed nature of obstetric cholestasis and increased risk of stillbirth in twin pregnancies.\\n\\n\\nReassured about ongoing monitoring and early delivery plan.\\n\\n\\nAdvised to monitor fetal movements closely and report any reduction.\\n\\n\\nProvided written information and contact details for triage if symptoms worsen.\\n\\n\\nDictated by: Dr. [Fictional Name] Patel\\n Date: [Fictional Date]\\n--Note: This is a fictional dictation for testing purposes only. No real patient data or medical advice is contained herein.\\n\\n\\n\\nGuideline:\\n[ID] cg20013-preterm-birth-risk-pathway-pdf\\nTitle: CG20013 Preterm birth risk pathway\\nContent: No content available\",\n  \"system_prompt\": \"You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.\",\n  \"guideline_id\": \"cg20013-preterm-birth-risk-pathway-pdf\",\n  \"guideline_title\": \"CG20013 Preterm birth risk pathway\"\n}\n\nA: Since the guideline content (CG20013 Preterm birth risk pathway) is not available for review, I cannot make specific recommendations tied to that guideline. However, based on standard obstetric practice for twin pregnancies with suspected obstetric cholestasis, I can provide general recommendations for improvement of this clinical note:\n\n### Very Important Recommendations\n1. [Additional information needed] - Document baseline bile acid levels from booking bloods if available, or explicitly state they were not done\nReason: Baseline bile acids are crucial for comparison in suspected obstetric cholestasis cases (RCOG Green-top Guideline No. 43)\n\n2. [Different management plan] - Consider admission for monitoring given twin pregnancy with suspected cholestasis\nReason: Twin pregnancies with cholestasis have higher risk of adverse outcomes and may benefit from closer inpatient monitoring (RCOG)\n\n### Somewhat Important Recommendations\n1. [Additional information needed] - Document detailed counseling about specific risks of preterm delivery in twin pregnancy with cholestasis\nReason: Patients should understand the balance between fetal risks from cholestasis versus prematurity (SMFM guidelines on twin pregnancy)\n\n2. [Improved patient advice] - Provide specific written information about signs of preterm labor to watch for\nReason: Twin pregnancies have higher risk of preterm labor, especially with cholestasis (ACOG practice bulletin on multifetal gestations)\n\n### Less Important Recommendations\n1. [Additional information needed] - Consider adding total weight gain in pregnancy to documentation\nReason: Weight gain patterns may be relevant in twin pregnancies (NIH guidelines on twin pregnancy management)\n\n2. [Improved patient advice] - Suggest specific non-pharmacological itch relief measures (cool baths, loose clothing)\nReason: Can improve quality of life while awaiting medication effects (RCOG patient information leaflets)\n\nWithout access to the specific CG20013 guideline content, I cannot make recommendations that directly reference it. The recommendations above are based on general obstetric guidelines for management of twin pregnancies with suspected cholestasis. To provide more targeted feedback, the full text of the CG20013 guideline would need to be available for review.\n\n--- Token Usage Report ---\nPrompt tokens: 1043\nCompletion tokens: 420\nTotal tokens: 1463\nEstimated cost: $0.000731",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": {
    "prompt_tokens": 1043,
    "completion_tokens": 420,
    "total_tokens": 1463,
    "estimated_cost_usd": 0.0007314999999999999
  }
}